Skip to content

Long COVID in Children

Long COVID in Children - LongCOCid

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028523
Enrollment
150
Registered
2022-06-14
Start date
2022-05-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U08.9 LONG COVID

Interventions

Group 1: Work package 1 will study 150 children and adolescents aged 6-18 years who present to the Long Covid outpatient clinic following referral by their pediatrician.

Sponsors

Universitätsklinik Jena
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 17 Years

Inclusion criteria

Inclusion criteria: -Consent to data collection and examination/archiving of biomaterials -Boys and girls who meet diagnostic criteria for Long Covid: Evidence of previous SARS-CoV-2 infection (pos. SARS-CoV-2 PCR test and/or pos. SARS-CoV-2 antibody and a definite contact with a person with proven SARS-CoV-2 infection). and Presence of one or more symptoms compatible with Long COVID persisting longer than 4 weeks after infection and/or setting new on after initial recovery and relevant impairment of activities of daily life and no evidence for other causes wich could explain symptoms

Exclusion criteria

Exclusion criteria: - Pregnancy - Diagnosis of a disease that explains part of the symptoms and arose independently of the SARS CoV-2 infection.

Design outcomes

Primary

MeasureTime frame
Primary objective: Characterization of Long COVID-19 according to clinical, laboratory, functional and psychological aspects. Correlation to measurable organ damage, influence on quality of life. Main parameter: change in quality of life caused by Long COVID-19 in childhood and adolescence, measured with SF 12.

Secondary

MeasureTime frame
Secondary objectives/questions: What clues to the pathogenesis of long covid-19 can be elicited? What is the course of the disease? Can diagnostic criteria be established, or refined? Correlation to comorbidities. Correlation of functional diagnostics and laboratory with symptoms/suffering. Identification of disease-specific biomarkers. Secondary outcome measures: Clinical, laboratory, functional, and psychological changes at initial presentation and 3-month follow-up.

Countries

Germany

Contacts

Public ContactDaniel Vilser

Klinik für Kinder und JugendmedizinUniversitätsklinikum Jena

daniel.vilser@med.uni-jena.de036419329540

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026